EN IT

Reserved

Hims & Hers Health: ingresso selettivo con forza alta e volatilità da gestire

·46 min read
EXECUTIVE VIEW

Hims & Hers Health riceve un segnale di acquisto fresco, seconda posizione fra i 12 nuovi Long sui titoli statunitensi. Forza a 76 su 100, volatilità elevata: il profilo è ad alta convinzione, ma richiede disciplina nella gestione del rischio.

Reserved analysis Subscribe to read →
Reserved

Hims & Hers Health: selective entry, high strength and volatility to manage

·45 min read
EXECUTIVE VIEW

Hims & Hers Health weekly technical analysis — fresh buy signal, 2nd out of 12 US stock setups. Signal strength at 76 out of 100, elevated volatility: high-conviction trade setup, but requires strict risk management.

Reserved analysis Subscribe to read →
Reserved

Hims & Hers Health: segnale di vendita in difficoltà, la conferma chiude in salita

·44 min read
EXECUTIVE VIEW

Alla 3ª settimana di un segnale di vendita, Hims & Hers Health ha chiuso la settimana di conferma in salita: la disciplina suggerisce di uscire dalla posizione short. Operatività nuova sconsigliata: doppio minimo sul daily e volatilità elevata rendono il quadro ambiguo.

Reserved analysis Subscribe to read →
Reserved

Hims & Hers Health: sell signal under pressure as confirmation week closes bullish

·43 min read
EXECUTIVE VIEW

At week 3 of a sell signal, Hims & Hers Health closed the confirmation week bullish: discipline points to exiting the short position. New entries not recommended: a strong daily double bottom and elevated volatility make the picture ambiguous.

Reserved analysis Subscribe to read →
Reserved

Hims & Hers Health: la conferma chiude al rialzo, il quadro resta incerto

·43 min read
EXECUTIVE VIEW

Hims & Hers Health è alla 2ª settimana di un segnale di vendita, ma la conferma si è chiusa al rialzo. IQS a 39 su 100 in fase ordinaria, 94ª posizione fra i 96 segnali di vendita USA. Banda di qualità: operatività sconsigliata.

Reserved analysis Subscribe to read →
Reserved

Hims & Hers Health: confirmation closes bullish, picture remains unclear

·42 min read
EXECUTIVE VIEW

Hims & Hers Health is in the 2nd week of a sell signal, but the confirmation week closed bullish. IQS at 39 out of 100 in ordinary phase, ranked 94th among 96 US sell signals. Quality band: trading not recommended.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn